Inozyme Pharma, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
INZY on Nasdaq
Industry
Pharmaceutical Preparations
Location
321 Summer Street, Suite 400, Boston, MA

Insiders trading volume in the past year

Inozyme Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Longitude Capital Partners III, LLC 10%+ Owner $14.9M Apr 19, 2022
Pivotal bioVenture Partners Fund I, L.P. Director $5.61M Aug 1, 2023
Henric Bjarke Svp, Coo $376K Dec 15, 2022
Matthew Winton Coo $185K Jul 1, 2025
Sanjay Subramanian SVP, CFO & Head of BD $171K Jul 1, 2025
Douglas A. Treco CEO & Chairman, Director $38.5K -$7.85K -16.9% Jul 1, 2025
Robert Lorne Hopfner Director $0 Jul 1, 2025
Axel Bolte Director $0 Jul 1, 2025
Inozyme Pharma, Inc. Director Jun 23, 2021
Edward T. Mathers Director Jun 18, 2024
Stephen J. DiPalma Interim CFO May 17, 2021
Lynne Sullivan Director Jul 1, 2025
Sarah Bhagat Director Jun 18, 2024
Erik Harris Director Oct 3, 2024
Reinaldo M. Diaz Director Jun 18, 2024
Martin Edwards Director Jun 18, 2024

Recent Insider Transactions by Companies or Individuals for Inozyme Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.